Triptolide delivery: Nanotechnology-based carrier systems to enhance efficacy and limit toxicity

Pharmacol Res. 2021 Mar:165:105377. doi: 10.1016/j.phrs.2020.105377. Epub 2021 Jan 20.

Abstract

Triptolide (TP) possesses a wide range of biological and pharmacological activities involved in the treatment of various diseases. However, widespread usages of TP raise the urgent issues of the severe toxicity, which hugely limits its further clinical application. The novel functional nanostructured delivery system, which is of great significance in enhancing the efficacy, reducing side effects and improving bioavailability, could improve the enrichment, penetration and controlled release of drugs in the lesion location. Over the past decades, considerable efforts have been dedicated to designing and developing a variety of TP delivery systems with the intention of alleviating the adverse toxicity effects and enhancing the bioavailability. In this review, we briefly summarized and discussed the recent functionalized nano-TP delivery systems for the momentous purpose of guiding further development of novel TP delivery systems and providing perspectives for future clinical applications.

Keywords: Bioavailability; Nanostructured delivery system; Side effects; Triptolide.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Diterpenes / administration & dosage*
  • Diterpenes / therapeutic use
  • Diterpenes / toxicity
  • Drug Carriers*
  • Epoxy Compounds / administration & dosage
  • Epoxy Compounds / therapeutic use
  • Epoxy Compounds / toxicity
  • Humans
  • Nanoparticle Drug Delivery System*
  • Phenanthrenes / administration & dosage*
  • Phenanthrenes / therapeutic use
  • Phenanthrenes / toxicity

Substances

  • Diterpenes
  • Drug Carriers
  • Epoxy Compounds
  • Nanoparticle Drug Delivery System
  • Phenanthrenes
  • triptolide